Title : [Clinical Efficacy and Prognostic Factors of Decitabine for Treatment of Myelodysplastic Syndrome].

Pub. Date : 2018 Dec

PMID : 30501707






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Among 87 patients received decitabine treatment, the TP53 gene mutation occured in 11 (12.6%) patients. Decitabine tumor protein p53 Homo sapiens
2 Multivariate logistic regression model showed that the complex karyotype, Plt count doubling after 1 course treatment, TP53 mulation and high expression of hENT1 mRNA were the independent prognostic factors for predicting the CR after decitabine treatment. Decitabine tumor protein p53 Homo sapiens